IL-2/IL-2Ab complexes induce regulatory T cell expansion and protect against proteinuric CKD

Journal of the American Society of Nephrology

Volumn 23, Issue 8, 2012, Pages 1303-1308

  Polhill, Tania ^a   Zhang, Geoff Yu ^a   Hu, Min ^a   Sawyer, Andrew ^a   Zhou, Jimmy Jianheng ^a   Saito, Mitsuru ^a   Webster, Kylie E ^b   Wang, Ya ^c   Wang, Yiping ^c   Grey, Shane T ^b   Sprent, Jonathan ^b   Harris, David C H ^c   Alexander, Stephen I ^a   Wang, Yuan Min ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2 DERIVATIVE; INTERLEUKIN 2 INTERLEUKIN 2AB COMPLEX; INTERLEUKIN 6; MONOCLONAL ANTIBODY; STAT5 PROTEIN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CD4+ T LYMPHOCYTE; CELL EXPANSION; CHRONIC KIDNEY DISEASE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG EFFICACY; FOCAL GLOMERULOSCLEROSIS; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INJURY SEVERITY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEINURIA; REGULATORY T LYMPHOCYTE; RENAL PROTECTION; SPLEEN;

EID: 84864855006     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011111130     Document Type: Article

References (21)

1. Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061, 2003
2. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T: Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212: 8-27, 2006
3. Sakaguchi S: Regulatory T cells in the past and for the future. Eur J Immunol 38: 901-937, 2008
4. Wang YM, Zhang GY, Wang Y, Hu M, Wu H, Watson D, Hori S, Alexander IE, Harris DC, Alexander SI: Foxp3-transduced polyclonal regulatory T cells protect against chronic renal injury from adriamycin. J Am Soc Nephrol 17: 697-706, 2006
5. Mahajan D, Wang Y, Qin X, Wang Y, Zheng G, Wang YM, Alexander SI, Harris DC: CD4+CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease. J Am Soc Nephrol 17: 2731-2741, 2006
6. Kim HP, Kelly J, Leonard WJ: The basis for IL-2-induced IL-2 receptor alpha chain gene regulation: Importance of two widely separated IL-2 response elements. Immunity 15: 159-172, 2001
7. Beyersdorf N, Ding X, Blank G, Dennehy KM, Kerkau T, Hünig T: Protection from graft-versus-host disease with a novel B7 binding site-specific mouse anti-mouse CD28 monoclonal antibody. Blood 112: 4328-4336, 2008
8. Varker KA, Kondadasula SV, Go MR, Lesinski GB, Ghosh-Berkebile R, Lehman A, Monk JP, Olencki T, Kendra K, Carson WE 3rd: Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy. Clin Cancer Res 12: 5850-5858, 2006
9. Takabatake Y, Li XK, Mizui M, Miyasato K, Matsui I, Kawada N, Imai E, Hünig T, Takahara S, Wada T, Furuichi K, Rakugi H, Isaka Y: A superagonistic monoclonal antibody for CD28 ameliorates crescentic glomerulonephritis in wistar-kyoto rats. Mol Med 17: 686-696, 2011
10. Ohkura N, Hamaguchi M, Sakaguchi S: FOXP3+ regulatory T cells: Control of FOXP3 expression by pharmacological agents. Trends Pharmacol Sci 32: 158-166, 2011
11. Nelson BH: IL-2, regulatory T cells, and tolerance. J Immunol 172: 3983-3988, 2004
12. Tomala J, Chmelova H, Mrkvan T, Rihova B, Kovar M: In vivo expansion of activated naive CD8+ T cells and NK cells driven by complexes of IL-2 and anti-IL-2 monoclonal antibody as novel approach of cancer immunotherapy. J Immunol 183: 4904-4912, 2009
13. Webster KE, Walters S, Kohler RE, Mrkvan T, Boyman O, Surh CD, Grey ST, Sprent J: In vivo expansion of T reg cells with IL-2-mAb complexes: Induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J Exp Med 206: 751-760, 2009
14. Barron L, Dooms H, Hoyer KK, Kuswanto W, Hofmann J, O'Gorman WE, Abbas AK: Cutting edge: mechanisms of IL-2-dependent maintenance of functional regulatory T cells. J Immunol 185: 6426-6430, 2010
15. Wilson MS, Pesce JT, Ramalingam TR, Thompson RW, Cheever A, Wynn TA: Suppression of murine allergic airway disease by IL-2:anti-IL-2 monoclonal antibody-induced regulatory T cells. J Immunol 181: 6942-6954, 2008
16. Phelan JD, Orekov T, Finkelman FD: Cutting edge: mechanism of enhancement of in vivo cytokine effects by anti-cytokine monoclonal antibodies. J Immunol 180: 44-48, 2008
17. Gogishvili T, Langenhorst D, Lühder F, Elias F, Elflein K, Dennehy KM, Gold R, Hünig T: Rapid regulatory T-cell response prevents cytokine stormin CD28 superagonist treated mice. PLoS ONE 4: e4643, 2009
18. Saadoun D, Rosenzwajg M, Joly F, Six A, Carrat F, Thibault V, Sene D, Cacoub P, Klatzmann D: Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N Engl J Med 365: 2067-2077, 2011
19. Koreth J, Matsuoka K, Kim HT, McDonough SM, Bindra B, Alyea EP 3rd, Armand P, Cutler C, Ho VT, Treister NS, Bienfang DC, Prasad S, Tzachanis D, Joyce RM, Avigan DE, Antin JH, Ritz J, Soiffer RJ: Interleukin-2 and regulatory T cells in graft-versus-host disease. N Engl J Med 365: 2055-2066, 2011
20. Bluestone JA: The yin and yang of interleukin-2-mediated immunotherapy. N Engl J Med 365: 2129-2131, 2011
21. Boyman O, Surh CD, Sprent J: Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease. Expert Opin Biol Ther 6: 1323-1331, 2006